Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 6.29
-0.22 (-3.38%)
Apr 17, 2026, 2:15 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 11.75 billion as of April 16, 2026. Its market cap has increased by 96.76% in one year.
Market Cap
11.75B
Enterprise Value
11.83B
Revenue
1.04B
Ranking
n/a
PE Ratio
39.28
Stock Price
6.29
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 11.75B, a decrease of -0.80%. That is a compound annual growth rate of -0.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 11.19B | 24.75% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CStone Pharmaceuticals | 14.58B |
| Everest Medicines | 13.10B |
| HBM Holdings | 11.57B |
| CARsgen Therapeutics Holdings | 10.45B |
| Alphamab Oncology | 10.44B |
| Guangzhou Innogen Pharmaceutical Group | 9.35B |
| Shanghai Haohai Biological Technology | 9.26B |
| Abbisko Cayman | 8.62B |